V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001474 | 230001474 | null | null | null | null | 2018-12-02 | CARBOPLATIN + PACLITAXEL | null | null | CARBOPLATIN + PACLITAXEL | 100297309 |
| 230001477 | 230001477 | null | null | Adjuvant (A) | 2019-09-16 | 2019-09-24 | Carboplatin 21day + Paclitaxel 7day | 02 | N | CARBOPLATIN + PACLITAXEL | 101487606 |
| 230001483 | 230001483 | null | null | null | null | 2017-11-09 | null | null | null | PEMETREXED | 100608737 |
| 230001493 | 230001493 | null | null | null | null | 2019-11-19 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100010292 |
| 230001496 | 230001496 | 1.5 | 64.9 | Adjuvant (A) | 2018-09-23 | 2018-09-30 | CARBOPLATIN | null | N | CARBOPLATIN | 100135892 |
| 230001499 | 230001499 | null | null | null | null | 2016-12-18 | ICON8B TRIAL | 02 | null | BEVACIZUMAB + CARBO + PACLITAXEL | 100260155 |
| 230001503 | 230001503 | 1.6 | 79.9 | null | null | 2019-07-20 | CARBOPLATIN + PACLITAXEL | N | N | CARBOPLATIN + PACLITAXEL | 101241891 |
| 230001506 | 230001506 | null | null | null | null | 2018-10-20 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101191380 |
| 230001509 | 230001509 | 1.65 | 47.6 | null | null | 2019-04-11 | CARBOPLATIN + PACLITAXEL | null | N | CARBOPLATIN + PACLITAXEL | 100937617 |
| 230001510 | 230001510 | null | null | null | null | 2019-10-26 | CARBOPLATIN | null | null | CARBOPLATIN | 101773205 |
| 230001511 | 230001511 | 1.6 | 110 | Adjuvant (A) | null | 2019-02-26 | ICON8 TRIAL | null | N | ICON8B TRIAL | 100713331 |
| 230001517 | 230001517 | null | null | null | null | 2019-03-19 | Niraparib | null | null | BEVACIZUMAB + CARBO | 101482927 |
| 230001521 | 230001521 | null | null | null | null | 2017-01-10 | CARBOPLATIN + PACLITAXEL | null | null | CARBOPLATIN + PACLITAXEL | 101062463 |
| 230001524 | 230001524 | 1.56 | 52.5 | null | null | 2018-10-09 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100203552 |
| 230001528 | 230001528 | 1.65 | 60.6 | null | 2017-12-01 | 2017-12-13 | Carboplatin + Paclitaxel (3 weekly) | null | N | CARBOPLATIN + PACLITAXEL | 100311026 |
| 230001529 | 230001529 | 1.57 | 77.85 | Neo-adjuvant (N) | 2018-05-19 | 2018-05-22 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100988727 |
| 230001532 | 230001532 | null | null | null | null | 2019-08-16 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 100311618 |
| 230001534 | 230001534 | 1.66 | 76.7 | null | 2016-09-11 | 2016-09-19 | Bevacizumab + CARBOPLATIN + PACLITAXEL | null | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100827891 |
| 230001538 | 230001538 | null | null | null | null | 2020-05-10 | IPILIMUMAB + NIVOLUMAB | null | null | ICON TRIAL | 101721726 |
| 230001541 | 230001541 | null | null | Palliative (P) | null | 2020-12-15 | Carboplatin AUC 2 - 5 | null | N | CARBOPLATIN | 100263112 |
| 230001542 | 230001542 | null | null | null | null | 2019-01-07 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 100441216 |
| 230001546 | 230001546 | null | null | null | null | 2019-04-29 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100037302 |
| 230001552 | 230001552 | null | 64 | Palliative (P) | null | 2018-08-09 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101200011 |
| 230001553 | 230001553 | 1.59 | 51 | Neo-adjuvant (N) | 2019-06-12 | 2019-06-15 | CARBOPLATIN + PACLITAXEL | null | N | CARBOPLATIN + PACLITAXEL | 100909095 |
| 230001556 | 230001556 | null | null | null | null | 2019-08-27 | CARBOPLATIN + PACLITAXEL | 99 | null | CARBOPLATIN + PACLITAXEL | 100048559 |
| 230001560 | 230001560 | null | null | null | null | 2018-04-05 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 101412796 |
| 230001561 | 230001561 | null | null | null | null | 2018-12-16 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 101444813 |
| 230001562 | 230001562 | 1.63 | 71 | Neo-adjuvant (N) | 2017-12-11 | 2017-12-23 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100161300 |
| 230001564 | 230001564 | null | null | null | null | 2019-07-07 | CARBOPLATIN + PACLITAXEL | null | null | CARBOPLATIN + PACLITAXEL | 100295757 |
| 230001566 | 230001566 | 1.66 | 64 | null | 2012-05-05 | 2012-05-07 | CARBOPLATIN + PACLITAXEL | null | N | CARBOPLATIN + PACLITAXEL | 100959246 |
| 230001569 | 230001569 | null | null | Adjuvant (A) | 2014-09-08 | 2014-09-18 | Carboplatin 21day + Paclitaxel 7day | null | N | CARBOPLATIN + PACLITAXEL | 101587723 |
| 230001571 | 230001571 | null | null | null | null | 2016-12-31 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100538691 |
| 230001576 | 230001576 | 1.59 | 63.5 | null | null | 2018-10-02 | Carboplatin + Paclitaxel (3 weekly) | N | N | CARBOPLATIN + PACLITAXEL | 100457086 |
| 230001579 | 230001579 | 1.65 | 79.9 | Neo-adjuvant (N) | 2021-01-22 | 2021-01-28 | null | 02 | N | TRIAL UNSPECIFIED | 100164094 |
| 230001580 | 230001580 | null | null | null | null | 2019-11-06 | Bevacizumab+Carbo+Pacliaxel | null | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100700908 |
| 230001581 | 230001581 | null | null | Neo-adjuvant (N) | null | 2018-11-18 | Carboplatin + Paclitaxel (3 weekly) | null | N | CARBOPLATIN + PACLITAXEL | 100520668 |
| 230001585 | 230001585 | null | null | null | null | 2021-02-05 | Carboplatin AUC 6 - 10 | null | null | CARBOPLATIN | 101539767 |
| 230001587 | 230001587 | 1.54 | null | Palliative (P) | 2019-05-20 | 2019-05-30 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 101836585 |
| 230001593 | 230001593 | null | null | null | null | 2019-10-31 | CARBOPLATIN + PACLITAXEL | null | null | CARBOPLATIN + PACLITAXEL | 101052169 |
| 230001594 | 230001594 | null | null | null | null | 2017-10-20 | Bevacizumab+Carbo+Pacliaxel | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101743200 |
| 230001595 | 230001595 | null | null | Neo-adjuvant (N) | null | 2019-12-11 | Carboplatin + Paclitaxel (3 weekly) | null | N | CARBOPLATIN + PACLITAXEL | 100293287 |
| 230001596 | 230001596 | 1.62 | 63.6 | Neo-adjuvant (N) | 2017-08-20 | 2017-09-18 | Carboplatin + Paclitaxel (3 weekly) | null | N | CARBOPLATIN + PACLITAXEL | 100585531 |
| 230001599 | 230001599 | 1.7 | 0 | null | null | 2019-10-02 | Carboplatin + Paclitaxel (3 weekly) | null | N | CARBOPLATIN + PACLITAXEL | 101790990 |
| 230001608 | 230001608 | 1.52 | 69.2 | null | null | 2019-06-18 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100835010 |
| 230001611 | 230001611 | null | null | null | null | 2018-10-17 | null | 1 | null | CARBOPLATIN + GEMCITABINE | 100754810 |
| 230001614 | 230001614 | null | null | null | null | 2018-05-23 | null | 02 | null | BEVACIZUMAB | 101497966 |
| 230001618 | 230001618 | 1.67 | 60.1 | Palliative (P) | 2019-06-17 | 2019-07-07 | Carboplatin AUC 2 - 5 | null | N | CARBOPLATIN | 100341336 |
| 230001626 | 230001626 | null | null | null | null | 2019-07-07 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101371895 |
| 230001627 | 230001627 | null | null | null | null | 2018-10-05 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101340510 |
| 230001628 | 230001628 | 1.54 | 70 | Adjuvant (A) | 2019-04-07 | 2019-04-28 | Carboplatin AUC 2 - 5 | null | N | CARBOPLATIN | 101716201 |